1. Home
  2. EVTC vs NVCR Comparison

EVTC vs NVCR Comparison

Compare EVTC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evertec Inc.

EVTC

Evertec Inc.

HOLD

Current Price

$29.98

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$17.82

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVTC
NVCR
Founded
1988
2000
Country
United States
Switzerland
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.0B
IPO Year
2013
2015

Fundamental Metrics

Financial Performance
Metric
EVTC
NVCR
Price
$29.98
$17.82
Analyst Decision
Hold
Buy
Analyst Count
5
6
Target Price
$35.80
$28.08
AVG Volume (30 Days)
384.3K
1.2M
Earning Date
05-06-2026
04-30-2026
Dividend Yield
0.67%
N/A
EPS Growth
27.17
21.79
EPS
0.47
N/A
Revenue
$453,869,000.00
$655,353,000.00
Revenue This Year
$12.68
$7.72
Revenue Next Year
$6.86
$6.74
P/E Ratio
$62.70
N/A
Revenue Growth
11.48
8.28
52 Week Low
$21.81
$9.82
52 Week High
$35.41
$21.45

Technical Indicators

Market Signals
Indicator
EVTC
NVCR
Relative Strength Index (RSI) 49.38 55.67
Support Level $28.87 $14.84
Resistance Level $30.38 $18.41
Average True Range (ATR) 0.93 0.74
MACD -0.17 0.06
Stochastic Oscillator 28.55 66.01

Price Performance

Historical Comparison
EVTC
NVCR

About EVTC Evertec Inc.

Evertec Inc is a transaction processing business in Latin America and the Caribbean. Its business segments are Merchant Acquiring, Payment Services - Puerto Rico & Caribbean, Latin America Payments and Solutions, and Business Solutions. Latin America Payments and Solutions segment derive maximum revenue. The company serves a diversified customer base of financial institutions, merchants, corporations, and government agencies with mission-critical technology solutions that enable them to issue, process, and accept transactions securely. Geographically, it operates in Puerto Rico, Caribbean, and Latin America.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.

Share on Social Networks: